Strategy of STAT3β cell-specific expression in macrophages exhibits antitumor effects on mouse breast cancer

Gene Ther. 2015 Dec;22(12):977-83. doi: 10.1038/gt.2015.70. Epub 2015 Oct 1.

Abstract

Recent studies underscore the importance of crosstalk between tumor-associated macrophages (TAMs) and tumor cells in cancer progression and metastasis. In our study, AdCD68STAT3β, a recombinant adenovirus containing a STAT3β gene driven by CD68 macrophage-specific promoter, was used to suppress STAT3 and the downstream signaling pathways in TAMs. The results showed that STAT3β gene under the control of CD68 macrophage-specific promoter was only expressed in macrophages, which significantly inhibited the motility and invasion of breast cancer cells when co-cultured with 4T1 cells. Moreover, cell-specific STAT3β expression in TAMs extended survival of tumor-bearing mice and suppressed breast tumor growth, angiogenesis and metastasis, by regulating the crosstalk between tumor cells and TAMs. Therefore, our study provided a novel strategy for the antitumor effects of STAT3β.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae / genetics
  • Adenoviridae / metabolism
  • Animals
  • Antineoplastic Agents
  • Cell Line, Tumor
  • Cell Movement / physiology
  • Cell Proliferation / drug effects
  • Coculture Techniques
  • Female
  • Gene Expression
  • HEK293 Cells
  • Humans
  • Macrophages / immunology*
  • Macrophages / metabolism*
  • Mammary Neoplasms, Experimental / genetics
  • Mammary Neoplasms, Experimental / immunology
  • Mammary Neoplasms, Experimental / therapy*
  • Mice
  • Mice, Inbred BALB C
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • STAT3 Transcription Factor / biosynthesis*
  • STAT3 Transcription Factor / genetics
  • Signal Transduction

Substances

  • Antineoplastic Agents
  • Recombinant Proteins
  • STAT3 Transcription Factor